Lung Cancer Journal Articles

• CMS Should Have Required a Randomized Trial of F1CDx Authors give five reasons why CMS should have refrained from coverage of a 324-gene panel offered by Foundation Medicine in the absence of a randomized trial.
  Annals of Oncology, April 2018
• Targeting DNA Repair in SCLC and the Biomarker Landscape Areas of investigation for SCLC include identification of predictive biomarkers, effective combinations to overcome resistance, and strategies for immunotherapy.
  Translational Lung Cancer Research, April 2018
• Celiac Disease in Later Life Must Not Be Missed Celiac disease may manifest at any age. How prevalent is it in older persons, and how might symptoms present?
  Alimentary Pharmacology & Therapeutics, April 2018
• CAR T and Other T Cell Strategies for Pancreatic Cancer Review the biology of T cell therapy and its potential role in pancreatic cancer therapy.
  Chinese Clinical Oncology, March 2018
• Mortality After Hospitalization for a COPD Exacerbation Find out which factors may be associated with an increase in mortality among patients hospitalized for COPD exacerbations in the previous year.
  BMC Pulmonary Medicine, March 2018
• 'Hidden' Occupational Allergens Such as Additives A new review looks at the potential hidden allergens in the workplace. What do we know about the health effects associated with exposure to these agents?
  Current Opinion in Allergy and Clinical Immunology, March 2018
• Current Standards for Clinical Management of SCLC Review the latest on diagnosis, staging, and management of SCLC.
  Translational Lung Cancer Research, March 2018
• A Rapid Investigation Clinic for Lung Cancer Diagnosis Rapid access clinics could play an important role in the timely diagnosis, staging, and treatment of lung cancer.
  BMC Pulmonary Medicine, March 2018
• Review of Selected NMEs 2017 Learn about the profiles of recently approved new molecular entities in this review.
  U.S. Pharmacist, March 2018
• Risk Factors and Screening for Pancreatic Cancer Screening Review potential risk factors and current screening strategies for pancreatic cancer.
  Chinese Clinical Oncology, February 2018
• Alternative Medicine for Cancer and Its Impact on Survival Use of alternative medicine, without the use of conventional cancer therapy, may be associated with greater risk of death in curable cancer.
  Journal of the National Cancer Institute, February 2018
• Gemcitabine Plus Sirolimus for Osteosarcoma The combination of gemcitabine and sirolimus may be a safe and effective option for patients with relapsed unresectable osteosarcoma.
  Annals of Oncology, February 2018
• A Strategy for Building an LDCT Lung Cancer Screening Program A non-profit community health system presents their experience developing an LDCT lung cancer screening program, outlining a five-point strategy for ensuring success.
  Applied Radiology, February 2018
• RT and Targeted Therapy or Checkpoint Blockade in Brain Mets While more research is needed, most available studies find no relevant toxicity associated with the combination of radiotherapy and targeted therapy or immune checkpoint blockade for management of brain metastases.
  Annals of Oncology, February 2018
• Radiomics in Precision Medicine for Lung Cancer Potential uses for radiomics in lung cancer include basic image segmentation, outcome modeling, and even the deciphering of genetic signatures.
  Translational Lung Cancer Research, February 2018
• Depth of Response in NSCLC with Targeted or Immunotherapies Greater depth of response may be associated with overall survival and progression-free survival and could be considered as an additional outcome measure for clinical trials.
  Annals of Oncology, February 2018
• Tumor Biomarkers in Lung Cancer for Detection and Treatment Review the roles of circulating tumor cells, circulating tumor DNA, microRNA and other biomarkers for lung cancer management.
  Translational Lung Cancer Research, February 2018
• Representation of Minorities and Women in Oncology Trials Do clinical trials in oncology adequately represent the US population with cancer?
  Journal of Oncology Practice, February 2018
• Predictive and Prognostic Marker Assessments in Lung Cancer Advances in personalized medicine and histologic classification and staging are furthering lung cancer management.
  Translational Lung Cancer Research, January 2018
• Update on Large Cell Neuroendocrine Carcinoma Review molecular features and treatment options for large cell neuroendocrine carcinoma of the lung.
  Translational Lung Cancer Research, January 2018